A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Clinical trial NCT05210101 · COMPLETED

Trial details

NCT number: NCT05210101
Sponsor: Sophia Koo, M.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2022-02-07
Primary completion: 2023-02-28
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.